欧洲专利局（EPO）：2024抗癌专利和创新研究报告（英文版）（83页）.pdf

1、epo.orgPatents and innovation against cancerEvidence from patent and company dataFebruary 2024PATENTS AND INNOVATION AGAINST CANCERepo.org|02Foreword Medical advances are helping many of us to live longer.This means that we are more likely to encounter cancer in our own lives or in those of our clos

2、est family and friends.In the European Union,no fewer than 31%of men and 25%of women are expected to be diagnosed with cancer before reaching the age of 75.Innovation can give us hope for the future.Over 5 million lives have already been saved in the EU alone thanks to inventions in oncology.1 The f

3、ight against cancer is also increasingly at the forefront of research and innovation,spurred by recent technological breakthroughs and greater commitment from both the private and public sectors.Drawing on the EPOs expertly curated patent data,this study highlights a significant surge in innovation

4、aimed at combatting cancer in recent years:with patenting rising by over 70%,or almost 10%annually between 2015 and 2021.This report offers policymakers and investors key insights into the drivers behind this trend and their impact on the overall approach to innovation in related industries.The surg

5、e in cancer innovation is mainly driven by new technologies from immunotherapy and gene therapy to digital technologies such as AI that are opening up promising new avenues for diagnosis and treatment.It also largely stems from fundamental research,with universities and public research organisations

6、 alone accounting for almost a third of patenting activities.So intellectual property rights(IPRs)play a more important role than ever in supporting the commercialisation of next generation technologies against cancer.Indeed,IPRs not only protect inventions and attract investors,they also support co